2026 NPPES data Hematology & Oncology Physician NPI 1265490312 M.D., PH.D.
Verify on CMS →

NAIXI CHEN, M.D., PH.D.

Hematology & Oncology Physician in RENTON, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
826
Medicare Part D claims · 107 beneficiaries · Hematology & Oncology Physician avg: 847
Industry payments
$6.5K
239 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NAIXI CHEN, M.D., PH.D. filed 826 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in RENTON, Washington.

826
Part D claims, 2023
$6.5K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NAIXI CHEN, M.D., PH.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

826 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

NAIXI CHEN, M.D., PH.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NAIXI CHEN, M.D., PH.D.?

Quality data not reported

NPI registry status

Active

Issued 05/01/2006

NPI 1265490312

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

826 2% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Washington

How Hematology & Oncology Physician compares to other specialties among Washington providers

Washington providers

Hematology & Oncology Physician share within Washington

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAIXI CHEN, M.D., PH.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D., PH.D. credentials at 1412 SW 43RD ST STE 200, RENTON, WA, 98057, with a listed phone of (206) 588-1722. NPI 1265490312 was issued on 05/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 826 prescription claims written by this provider, covering 107 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, with an opioid prescribing rate of 9.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1412 SW 43RD ST STE 200
RENTON, WA 98057

Provider Details

NPI 1265490312
Specialty Hematology & Oncology Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 05/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAIXI CHEN, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$6.5K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to NAIXI CHEN, M.D., PH.D.. To verify NAIXI CHEN, M.D., PH.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

826
Total Claims
$1.7M
Total Drug Cost
107
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
948
Total Day Supply
22,989
Generic Drug Cost
$136K
Opioid Claims
76 (9.2% rate)
Antibiotic Claims
30

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
2.31
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NAIXI CHEN, M.D., PH.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ondansetron Odt
Ondansetron
50
Metoprolol Succinate
33
Alprazolam
29
Dexamethasone
29
Prochlorperazine Maleate
29
Fentanyl
25
Fulvestrant
23
Prednisone
23
Levothyroxine Sodium
22
Lidocaine-Prilocaine
Lidocaine/Prilocaine
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NAIXI CHEN, M.D., PH.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NAIXI CHEN, M.D., PH.D.'s 826 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as CHEN.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAIXI CHEN, M.D., PH.D.'s specialty?
NAIXI CHEN, M.D., PH.D. specializes in Hematology & Oncology Physician and practices in RENTON, Washington. Credentials: M.D., PH.D..
How much does NAIXI CHEN, M.D., PH.D. prescribe under Medicare Part D?
In 2023, NAIXI CHEN, M.D., PH.D. wrote 826 Medicare Part D claims totaling $1.7M in drug costs for 107 beneficiaries.
Where is NAIXI CHEN, M.D., PH.D. located?
NAIXI CHEN, M.D., PH.D. is located at 1412 SW 43RD ST STE 200, RENTON, WA, 98057. Phone: (206) 588-1722.
What is NAIXI CHEN, M.D., PH.D.'s NPI number?
NAIXI CHEN, M.D., PH.D.'s National Provider Identifier (NPI) is 1265490312, issued on 05/01/2006.
Does NAIXI CHEN, M.D., PH.D. prescribe opioids?
Yes, NAIXI CHEN, M.D., PH.D. had 76 opioid claims in 2023 with an opioid prescribing rate of 9.2%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NAIXI CHEN, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, NAIXI CHEN, M.D., PH.D.'s most frequently prescribed drugs include Ondansetron Odt, Metoprolol Succinate, Alprazolam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAIXI CHEN, M.D., PH.D. accept Medicare?
NAIXI CHEN, M.D., PH.D. appears in CMS Medicare data with 826 Part D claims and 107 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAIXI CHEN, M.D., PH.D.'s credentials?
NAIXI CHEN, M.D., PH.D.'s NPI is 1265490312 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology